St Jude Medical Newswire (Page 9)

St Jude Medical Newswire (Page 9)

Comprehensive Real-Time News Feed for St Jude Medical. (Page 9)

Results 161 - 180 of 1,390 in St Jude Medical

  1. Atlas Ip LLC v. Medtronic Inc UsaRead the original story w/Photo

    Oct 29, 2015 | FindLaw

    Before MOORE, REYNA, and TARANTO, Circuit Judges. George C. Summerfield, Jr., Stadheim & Grear, Ltd., Chicago, IL, argued for plaintiff-appellant.

    Comment?

  2. Atlas Ip LLC v. St Jude Medical IncRead the original story w/Photo

    Oct 29, 2015 | FindLaw

    Before MOORE, REYNA, and TARANTO, Circuit Judges. George C. Summerfield, Jr., Stadheim & Grear, Ltd., Chicago, IL, argued for plaintiff-appellant.

    Comment?

  3. St. James's Place plc Earns Buy Rating from Panmure GordonRead the original story

    Oct 27, 2015 | AmericanBankingNews.com

    's stock had its "buy" rating restated by Panmure Gordon in a research report issued to clients and investors on Tuesday, ARN reports. They presently have a GBX 1,125 price target on the stock.

    Comment?

  4. Outgoing St. Jude's CEO Dan Starks was hands-on in his approachRead the original story w/Photo

    Oct 24, 2015 | Star Tribune

    Dan Starks, who will step aside at the end of the year as CEO of St. Jude Medical, doesn't spend his time the way some CEOs of other big companies he's observed do, being what he called "administrators." From a start in management more than 30 years ago at a bankrupt medical devices company to the CEO of a Fortune 500 company with 18,000 employees, Dan Starks doesn't think his job has changed that much.

    Comment?

  5. St. Jude Medical Given "A" Credit RatingRead the original story

    Oct 23, 2015 | AmericanBankingNews.com

    St. Jude Medical has been given an "A" credit rating by analysts at Morningstar . The research firm's "A" rating indicates that the company is a low default risk.

    Comment?

  6. Current and Projected Cardiovascular Prosthetic Devices Market Size...Read the original story

    Oct 23, 2015 | PR.com

    Cardiovascular prosthetic devices are used to repair damaged or diseased natural valves of the heart. These devices are used to repair a damaged heart valve and to treat patient with a septal defect.

    Comment?

  7. Was Medtronic Right About St. Jude Medical's CardioMEMS?Read the original story w/Photo

    Oct 22, 2015 | Medical Device/Diagnostic Ind.

    St. Jude Medical cuts its revenue expectation for its novel congestive heart failure management device. Did a Medtronic executive have it right when he described CardioMEMS as an expensive solution? Here is a way by which accurate pressure readings of a heart failure patient's pulmonary artery is now available remotely and not just in a clinical setting.

    Comment?

  8. Barclays Reiterates Buy Rating for St. Jude MedicalRead the original story

    Oct 22, 2015 | AmericanBankingNews.com

    's stock had its "buy" rating reiterated by analysts at Barclays in a report issued on Thursday, AnalystRatingsNetwork.com reports. They currently have a $78.00 price objective on the medical technology company's stock.

    Comment?

  9. St. Jude Medical Stock Rating Reaffirmed by Credit SuisseRead the original story

    Oct 22, 2015 | AmericanBankingNews.com

    's stock had its "buy" rating reiterated by stock analysts at Credit Suisse in a report issued on Thursday, Analyst Ratings Net reports. They currently have a $75.00 price target on the medical technology company's stock.

    Comment?

  10. St. Jude Medical (STJ) Daniel J. Starks on Q3 2015 Results - Earnings Call TranscriptRead the original story w/Photo

    Oct 21, 2015 | Seeking Alpha

    Before we begin, let me remind you that some of the statements made during this conference call may be considered forward-looking statements. The company's 10-K for fiscal year 2014 and 10-Q for the fiscal quarter ended July 4, 2015 identify certain factors that could cause the company's actual results to differ materially from those projected in any forward-looking statements made this morning.

    Comment?

  11. What's The Deal With These Stocks Getting Pounded Today?Read the original story w/Photo

    Oct 21, 2015 | Insider Monkey

    Amid a strong day for the market which has seen several major companies post earnings beats and shares of Ferrari NV race out of the IPO starting gates, a handful of other companies are heading the wrong way on the valuation track. Let's find out what has soured investors on Pearson PLC , Polaris Industries Inc. , St. Jude Medical Inc. , EXCO Resources Inc , and Weight Watchers International, Inc. today and whether they could make for good investments on the dip.

    Comment?

  12. St. Jude cuts earnings forecast as sales, profit slipRead the original story w/Photo

    Oct 21, 2015 | TwinCities

    St. Jude Medical Inc. cut its full-year earnings forecast and said sales and profit slid in its latest quarter as the medical-device maker faced currency headwinds. While international sales declined 10 percent to $634 million, weighting on results, the Little Canada-based company met Wall Street expectations for earnings while narrowly missing the mark for revenue.

    Comment?

  13. St. Jude meets 3Q profit forecastsRead the original story

    Oct 21, 2015 | Marshall Independent

    On a per-share basis, the St. Paul, Minnesota-based company said it had profit of 75 cents. Earnings, adjusted for one-time gains and costs, came to 97 cents per share.

    Comment?

  14. St. Jude Medical lowers earnings outlookRead the original story w/Photo

    Oct 21, 2015 | Star Tribune

    St. Jude Medical trimmed its financial outlook for the year on Wednesday due in part to a delay in U.S. approval for a new pacemaker that's compatible with MRI scans. The Little Canada-based manufacturer of medical devices also said that it's lowering near-term sales expectations for a promising new heart sensor that monitors symptoms of early heart failure.

    Comment?

  15. St. Jude Medical Reports Third Quarter 2015 ResultsRead the original story

    Oct 20, 2015 | BioSpace

    St. Jude Medical, Inc. today reported sales and net earnings for its third quarter ended October 3, 2015. The company announced on October 8, 2015, that it had completed its acquisition of Thoratec, which did not affect the operational results of the company's third quarter.

    Comment?

  16. Mid-Morning Market Update: Markets Mostly Flat; General Motors Earnings Top ExpectationsRead the original story

    Oct 21, 2015 | Benzinga

    Following the market opening Wednesday, the Dow traded up 0.13 percent to 17,239.49 while the NASDAQ slipped 0.12 percent to 4,875.15. The S&P also rose, gaining 0.03 percent to 2,031.45.

    Comment?

  17. St. Jude cuts outlook as sales and profit slipRead the original story w/Photo

    Oct 21, 2015 | MarketWatch

    St. Jude Medical Inc. cut its full-year earnings forecast and said sales and profit slid in its latest quarter as the medical-device maker faced currency headwinds. While international sales declined 10% to $634 million, weighting on results, the St. Paul, Minn.-based company met Wall Street expectations for earnings while narrowly missing the mark for revenue.

    Comment?

  18. St. Jude Medical, Inc. (STJ) Updates Q4 Earnings GuidanceRead the original story

    Oct 21, 2015 | AmericanBankingNews.com

    St. Jude Medical, Inc. issued an update on its fourth quarter earnings guidance on Wednesday morning. The company provided earnings per share guidance of $1.00-1.02 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.07, ARN reports.

    Comment?

  19. S&P 500 Movers: STJ, KLACRead the original story

    Oct 21, 2015 | MarketNewsVideo

    ... has lost about 4.8% of its value. And the worst performing S&P 500 component thus far on the day is St Jude Medical (NYSE: STJ ), trading down 6.5%. St Jude Medical is lower by about 1.7% looking at the year to date performance. Two other components ...

    Comment?

  20. St. Jude Medical (STJ) Posts Quarterly Earnings Results, Meets ExpectationsRead the original story

    Oct 21, 2015 | AmericanBankingNews.com

    St. Jude Medical announced its earnings results on Wednesday. The medical technology company reported $0.97 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.97, Market Beat.com reports.

    Comment?